Shanghai Kehua Bio-engineering (002022.SZ) subsidiary obtains a medical device registration certificate.
Koha Biological (002022.SZ) announced that its controlling subsidiary, Xi'an Tianlong Technology Co., Ltd., has received approval from the National Drug Administration.
Shanghai Kehua Bio-engineering (002022.SZ) announced that its holding subsidiary, Xi'an Tianlong Technology Co., Ltd., has received a medical device registration certificate issued by the National Medical Products Administration. The product is called a Real-Time Fluorescent PCR Analyzer.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
